Brain Tumor Drugs Market Rising in United States | Fortune Business Insights
The global brain tumor drugs market size is projected to reach USD 5.64 billion in 2028. Governments of various countries are constantly trying to improve the healthcare infrastructure. Besides, multiple pharmaceutical companies are engaging in partnerships and collaborations to develop new brain tumor drugs. In May 2020, for instance, Perelman School of Medicine joined hands with Intel to accelerate a unique distributed machine learning technique. It would enable researchers worldwide to work together for developing novel deep learning initiatives without sharing data. Fortune Business Insights™ published this information in a new study, titled, “Brain Tumor Drugs Market, 2022-2028.” As per the study, the market stood at USD 2.35 billion in 2020 and hit USD 2.83 billion in 2022. It is set to exhibit a CAGR of 10.4% in the forecast period between 2022-2028.
Get
Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/brain-tumor-drugs-market-105025
North America |
United States, Canada and Mexico |
Europe |
Germany, UK, France, Italy, Russia and Turkey
etc. |
Asia-Pacific |
China, Japan, Korea, India, Australia, Indonesia,
Thailand, Philippines, Malaysia and Vietnam etc. |
South America |
Brazil, Argentina, Columbia etc. |
Middle East & Africa |
Saudi Arabia, UAE, Egypt, Nigeria and South
Africa |
NBTS Provides $100,000 to Curtana Pharmaceuticals for Researching on CT-179
In May 2020, National Brain Tumor
Society (NBTS) offered $100,000 to conduct research on CT-179, a novel drug
candidate developed by Curtana Pharmaceuticals for the treatment of
glioblastoma. As per one of the company officials, “The additional funding will
help us learn more about the capacity of this drug.”
COVID-19
to Bolster Growth Owing to Increasing Sales of Oncology Drugs
Several pharmaceutical companies are
striving to improve their supply chain management and quality control by
investing huge sums amid the COVID-19 pandemic. Roche’s quarterly reports of 2020, for instance, mentions that sales of its
pharmaceutical division surged by 7%. Its supply chain of tests and medicines
were intact throughout the pandemic. The growth was majorly driven by oncology
drugs, such as Perjeta and Tecentriq. Our research report will help you regain
your business confidence by utilizing the best available strategy.
Report
Coverage-
We follow a comprehensive research methodology that focuses majorly on delivering authentic and authentic information. We have utilized a data triangulation model which would aid us to offer accurate estimates and gauge the overall dynamics of the brain cancer drugs market. We also have gained access to multiple global and regional paid databases for delivering the latest information so that you can invest only in the vital areas.
Speak
To Our Analyst:
About Us:
Fortune Business Insights™ delivers accurate data and innovative
corporate analysis, helping organizations of all sizes make appropriate
decisions. We tailor novel solutions for our clients, assisting them to address
various challenges distinct to their businesses. Our aim is to empower them
with holistic market intelligence, providing a granular overview of the market
they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Comments
Post a Comment